See every side of every news story
Published loading...Updated

Aura Biosciences (NASDAQ:AURA) Earns Market Outperform Rating from JMP Securities

Summary by defenseworld.net
Aura Biosciences (NASDAQ:AURA – Get Free Report)‘s stock had its “market outperform” rating reissued by investment analysts at JMP Securities in a note issued to investors on Friday,Benzinga reports. They presently have a $19.00 price target on the stock. JMP Securities’ target price indicates a potential upside of 222.58% from the stock’s previous close. A number of other brokerages have also commented on AURA. HC Wainwright set a $25.00 price …

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Sunday, May 25, 2025.
Sources are mostly out of (0)